peptide-pulsed dendritic cell vaccination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for peptide-pulsed dendritic cell vaccination, covering 2025-02-24 to 2025-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Peptide-Pulsed Dendritic Cell Vaccination in Combination With Nivolumab and Ipilimumab for the Treatment of Recurrent and/or Progressive Diffuse Hemispheric Glioma, H3 G34-mutant [Phase 1]